Aledade Primary Care ACO LLC
4550 Montgomery Ave, Ste 950
Bethesda, MD 20814
| ACO Participants | ACO Participant in Joint Venture |
| Penn Medicine-PMA | N |
| Member First Name | Member Last Name | Member Title/Position | Member's Voting Power (Expressed as a percentage) | Membership Type | Practice Legal Business Name |
| MARK | BROWN | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| JONATHAN | BUSSENGER | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| CHRIS | DIDOMENICO | Board Member/Medicare Beneficiary Representative | 12.5 | Medicare Beneficiary Representative |
Penn Medicine-PMA |
| JOEL | EISNER | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| LEROY | FLEISCHER | Board Member/ACO Medical Director | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| JEFF | MANDEL | Board Member/Chair | 12.5 | Other | Aledade |
| MANJULA | RAMAN | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| KARL | SCHWABE | Board Member/Compliance Committee Lead | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| ROY | SCHWARTZ | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| CHARLES | SCHWARTZ | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| JILLIAN | WAWRZYNIAK | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
| YORK | YANG | Board Member | 7.5 | ACO Participant Representative |
Penn Medicine-PMA |
- Executive Director: Dr. Jeff Mandel
- Medical Director: Leroy Fleischer
- Compliance Officer: Ms. Amy Youtz
- Quality Assurance/Improvement Officer: Emily Maxson
| Committee Name | Committee Leader Name |
| Compliance Committee | Karl Schwabe / Compliance Committee Leader |
Networks of individual practices of ACO professionals.
-
Third Agreement Period
-
Performance Year 2021, $ 9,245,805
-
Performance Year 2020, $ 7,731,029
-
-
Second Agreement Period
-
Performance Year 2019, $0
-
-
First Agreement Period
- Performance Year 2018, $0
- Performance Year 2017, $0
- Performance Year 2016, $0
- Performance Year 2015, $0
Third Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 20%
- Proportion invested in redesigned care processes/resources: 30%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2020
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 35%
- Proportion of distribution to ACO participants: 55%
Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.